CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, April 23, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

FDA Continues to Combat Fraudulent COVID-19 Medical Products

admin - 0
May 07, 2020: "Today, the U.S. Food and Drug Administration is providing an update on the agency’s efforts to combat the extremely concerning actions...

Coronavirus (COVID-19) Update: Daily Roundup May 6, 2020

admin - 0
May 06, 2020: "The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19...

FDA Approves First Targeted Therapy for Lung Cancer

admin - 0
May 06, 2020: "U.S. Food and Drug Administration approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that...

Medical writing Module 2: Epidemiology and Evidence-Based Medicine

admin - 0
In module 1 i.e. induction of Medical Writing along with Types and Organisation name and What are skills required etc are covered. Have...

New targeted therapies first line for prostate cancer by ICMR

admin - 0
May 06, 2020: "The Institute of Cancer Research, London, has broadly welcomed the approval of targeted hormone therapies enzalutamide and abiraterone as first-line NHS treatments for men with...

NICE publishes rapid COVID-19 guideline for acute kidney injury

admin - 0
May 06, 2020: The National Institute for Health and Care Excellence has published a new COVID-19 rapid guideline on acute kidney injury (AKI). The...

AbbVie Announces Extension of Expiration Date for Allergan Notes

admin - 0
May 05, 2020: AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes and Expects No Further Extensions of Expiration Date AbbVie Inc....

Aberdeen researchers to use artificial intelligence to create test for COVID-19

admin - 0
May 05, 2020: "Aberdeen researchers will use artificial intelligence to try to fast-track a test to allow mass screening for COVID-19, after the £140,000...

Farxiga approved in the US for the treatment of heart failure in patients with heart failure with a reduced ejection fraction

admin - 0
May 06, 2020: "Farxiga is the first SGLT2 inhibitor proven to significantly reduce the risk of cardiovascular death and hospitalisation for heart failure AstraZeneca’s Farxiga (dapagliflozin) has been...

Coronavirus (COVID-19) Update: Daily Roundup May 5, 2020

admin - 0
May 05, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19...

FDA approves new treatment for a type of heart failure

admin - 0
May 05, 2020: "The U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction...

Study to determine the incidence of novel coronavirus infection in U.S. children begins

admin - 0
May 04, 2020: "NIH-funded study also will ascertain percentage of infected children who develop COVID-19. A study to help determine the rate of...
1...414243...65Page 42 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved